Stephenson L W, Friedman S, Edmunds L H
Circulation. 1978 Nov;58(5):837-41. doi: 10.1161/01.cir.58.5.837.
A cohort of 61 consecutive patients 24 months of age of younger had palliative shunts for symptoms of tetralogy of Fallot during a 12-year period. Thirty-six of these patients have been followed through definitive intracardiac repair or to death. For analysis palliative operations were separated into two six-year periods, 1965--1970. During the first period seven of 30 infants operated on died; all 31 infants operated on during the second period survived. The Waterston anastomosis was performed most frequently (67%) during the first period; the Blalock-Taussig anastomosis was performed in 68% of infants during the second period. Of 54 hospital survivors, three died before definitive intracardiac repair. Two of the three interim deaths were related to heart disease. Twenty-six of the remaining 51 patients have had definitive intracardiac repair with two deaths (8%). Twenty-four in this group had intracardiac repair since 1973 with one hospital death (4%). The cumulative mortality for the entire cohort is 25%, but more recent experience (1971--77) indicates a cumulative mortality near 5%. The recent mortality rate for staged management is less than the 14% rate reported by others for primary intracardiac repair of tetralogy of Fallot in 205 infants. We conclude that primary intracardiac repair has important advantages for infants with tetralogy of Fallot who have favorable anatomic features and no other associated cardiac lesions or medical problems. Staged management of tetralogy of Fallot is still recommended for infants with unfavorable anatomy, additional lesions or associated medical problems.
在12年期间,一组61例24个月及以下的连续患者因法洛四联症症状接受了姑息性分流术。其中36例患者已接受了确定性心内修复或随访至死亡。为了进行分析,姑息性手术被分为两个六年期,即1965年至1970年。在第一期,接受手术的30例婴儿中有7例死亡;在第二期接受手术的31例婴儿全部存活。在第一期,沃特斯顿吻合术最为常用(67%);在第二期,68%的婴儿接受了布劳洛克-陶西格吻合术。在54例医院幸存者中,3例在进行确定性心内修复前死亡。这3例中期死亡中有2例与心脏病有关。其余51例患者中有26例接受了确定性心内修复,2例死亡(8%)。该组中有24例自1973年以来进行了心内修复,1例医院死亡(4%)。整个队列的累积死亡率为25%,但最近的经验(1971年至1977年)表明累积死亡率接近5%。最近分期治疗的死亡率低于其他人报道的205例婴儿法洛四联症一期心内修复14%的死亡率。我们得出结论,对于具有良好解剖特征且无其他相关心脏病变或医疗问题的法洛四联症婴儿,一期心内修复具有重要优势。对于解剖结构不佳、有其他病变或相关医疗问题的婴儿,仍建议采用法洛四联症的分期治疗。